Title : RBL2/DREAM-mediated repression of the Aurora kinase A/B pathway determines therapy responsiveness and outcome in p53 WT NSCLC.

Pub. Date : 2022 Jan 20

PMID : 35058503






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Knockdown of p53, RBL2, or the DREAM component LIN37 increased AURKA/B pathway gene expression and reduced paclitaxel and radiation toxicity in NSCLC cells. Paclitaxel tumor protein p53 Homo sapiens